Role of Metformin on Recurrence-Free Survival (RFS) in Neuroendocrine Tumors (NET) Abstract #904

Introduction: Recent data suggest metformin (Met) has antineoplastic properties in different type of cancer. Effects of Met have never been investigated in NET.
Aim(s): To determine the role of Met on RFS in NET patients (pts).
Materials and methods: A retrospective analysis was conducted comparing NET pts with recent diagnosis (< 1 yr) of diabetes mellitus, with HbA1c≤7%, treated with Met (group A) to non-diabetic NET pts without Met (group B) with comparable clinical and pathological characteristics. RFS was evaluated by Kaplan-Meier analysis
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - Others
Presenting Author: Francesca Marciello

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result